RESUMEN
There has been an increase in costing analysis of intimate partner violence in recent decades, including the monetary impact to government, society, and the individual. Using data collected in a Canadian longitudinal study, the empirical analysis in this article provides an economic rationale for mobilizing public resources that improve the well-being of women leaving an abusive relationship. I estimated six variants of a selection model and used a costing exercise to build an economic case for preventive and other helping services to support women over their healing journey. The removal of financial constraints suffered by abused women, in support of their training needs, as well as reduced barriers to preventive health care services, may potentially lead to fiscal resource savings in the long run.
Asunto(s)
Mujeres Maltratadas/estadística & datos numéricos , Accesibilidad a los Servicios de Salud/economía , Apoyo Social , Maltrato Conyugal/economía , Servicios de Salud para Mujeres/economía , Adulto , Canadá , Femenino , Accesibilidad a los Servicios de Salud/estadística & datos numéricos , Humanos , Estudios Longitudinales , Persona de Mediana Edad , Programas Nacionales de Salud/organización & administración , Factores Socioeconómicos , Maltrato Conyugal/estadística & datos numéricos , Servicios de Salud para Mujeres/estadística & datos numéricos , Adulto JovenRESUMEN
The laboratory system in Manitoba for routine cervical screening is outdated and costly. We developed a costing framework for the implementation of new cervical cancer screening technology models. The direct healthcare costs in the baseline model, the conventional Papanicolaou smear test, were compared with estimates of two newer technology platforms, liquid-based cytology and human papillomavirus (HPV) testing. The findings revealed that HPV testing as a primary screening model for women aged 30 years and older represented the least-cost strategy. Liquid-based cytology would be used for routine screening of women under 30 years of age and to triage women 30 years and older whose results were HPV positive.